PR

Promimic AB

PRO · ST · Healthcare / Medical Devices

8.20SEK-0.05 (-0.61%)

Price History

Full chart

Market Stats

Previous Close8.25
Open8.20
Day Range8.20 – 8.20
52-Week Range7.70 – 19.45
Volume350
Market Cap185.14M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.40
Dividend Yield0.00%
Beta-0.32
50-Day Avg9.66
200-Day Avg11.44

About

Promimic AB (publ) engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden. It offers HAnano surface which combines several properties that are known to improve osseointegration into one unique surface modification; and nano-sized crystalline powder or suspension hydroxyapatite can be used in r and d, as an ingredient in bone substitutes or as a chromatography material. The company was incorporated in 2004 and is headquartered in Mölndal, Sweden.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Magnus Larsson
  • Employees17
  • HeadquartersEntreprenörsstråket 10, Mölndal, Sweden, 431 53, Sweden
  • Websitehttps://www.promimic.com

Leadership

  • Mr. Magnus LarssonChief Executive Officer · b. 1963
  • Mr. Ulf BrogrenChief Commercial Officer · b. 1973
  • Ms. Heidi BaderChief Financial Officer · b. 1981
  • Mr. Per KjellinChief Technology Officer · b. 1972
  • Mr. Christopher R. WhitfieldPresident of Promimic Inc · b. 1967

Financials

Income Statement

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue3.90M5.74M5.57M8.07M16.21M37.07M43.98M44.40M
Growth (%)-+47.29%-2.98%+44.78%+100.99%+128.63%+18.63%+0.96%
Cost of Revenue19.14M78.00K426.00K457.00K-411.00K-1.45M-4.01M51.99M
Gross Profit-15.24M5.67M5.15M7.61M16.63M38.52M47.98M-7.59M
Gross Margin-390.92%98.64%92.35%94.33%102.53%103.90%109.12%-17.10%
Operating Expense-116.80M18.74M22.86M32.38M47.63M56.31M-20.00K
Operating Income-15.24M-11.14M-13.59M-15.26M-15.76M-9.12M-8.32M-7.57M
Operating Margin-390.92%-193.91%-243.92%-189.10%-97.19%-24.60%-18.93%-17.06%
EBITDA-12.67M-9.42M-12.26M-13.86M-12.68M-3.68M-3.25M-2.81M
EBITDA Margin-325.07%-164.11%-220.06%-171.76%-78.19%-9.94%-7.38%-6.32%
Net Income-14.99M-11.29M-13.42M-15.19M-15.89M-9.22M-12.55M-8.80M
Net Income Margin-384.36%-196.67%-240.83%-188.26%-97.98%-24.88%-28.54%-19.82%
R&D--753.00K791.00K801.00K1.15M--
R&D as % of Total Revenue--13.51%9.81%4.94%3.10%--
Interest Expense330.61K319.00K481.00K150.00K166.00K92.00K-859.00K
Interest Expense % of Total Revenue8.48%5.55%8.63%1.86%1.02%0.25%-1.93%

Balance Sheet

Currency: SEK2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets24.45M32.56M44.55M32.16M92.77M92.88M88.07M75.71M
Total Liabilities7.23M6.62M7.27M9.60M11.46M16.16M18.15M16.60M
Total Equity17.22M25.94M37.59M22.57M81.32M76.72M69.91M59.11M
Cash4.20M11.91M25.00M9.36M58.80M50.32M35.77M20.60M
Total Debt4.42M833.00K2.99M2.36M268.06M259.30M--
Net Debt220.31K-11.08M-24.38M-8.52M-58.80M-50.32M-35.77M-20.60M

Cash Flow

Currency: SEK2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.10M-10.58M-14.62M-12.26M-3.75M-10.36M-4.20M
Investing Cash Flow--1.25M-869.00K-10.53M-9.37M-9.99M-8.82M
Financing Cash Flow-24.83M-583.00K72.16M4.93M5.18M-
Capital Expenditure01.25M869.00K10.53M5.79M9.99M1.78M
Free Cash Flow3.10M-11.84M-15.49M-22.80M-9.54M-10.36M-5.98M
FCF to OCF100.00%111.85%105.94%185.91%254.35%100.00%142.46%

Earnings

Report DateJun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------
EPS Actual-0.30-0.17-0.18-0.18-0.08-0.05-0.19-0.19-0.14-0.08-0.26-0.24-0.08-0.06-0.08-0.18-0.08
Surprise-----------------
Timing-----------------

Key Statistics & Ratios

Market Cap185.14M
Enterprise Value163.57M
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.10
Price / Book3.37
EPS-0.40
Book Value2.90
Revenue (TTM)45.20M
Gross Profit (TTM)37.65M
EBITDA-4.76M
Profit Margin-17.11%
Operating Margin-12.96%
Return on Equity-13.24%
Return on Assets-7.43%
Shares Outstanding18.89M
Shares Float18.74M
Beta-0.32
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%